BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31111216)

  • 1. The effect of maternal grafts in early acute cellular rejection after pediatric living-donor liver transplantation.
    Noguchi Y; Ueno T; Kodama T; Saka R; Takama Y; Tazuke Y; Bessho K; Okuyama H
    Pediatr Surg Int; 2019 Jul; 35(7):765-771. PubMed ID: 31111216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal grafts protect daughter recipients from acute cellular rejection after pediatric living donor liver transplantation for biliary atresia.
    Sanada Y; Kawano Y; Miki A; Aida J; Nakamura K; Shimomura N; Ishikawa N; Arai T; Hirata Y; Yamada N; Okada N; Wakiya T; Ihara Y; Urahashi T; Yasuda Y; Takubo K; Mizuta K
    Transpl Int; 2014 Apr; 27(4):383-90. PubMed ID: 24472036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased risk of graft failure with maternal liver transplantation in patients with biliary atresia.
    Nijagal A; Fleck S; Hills NK; Feng S; Tang Q; Kang SM; Rosenthal P; MacKenzie TC
    Am J Transplant; 2012 Feb; 12(2):409-19. PubMed ID: 22221561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durable Clinical and Immunologic Advantage of Living Donor Liver Transplantation in Children.
    Przybyszewski EM; Verna EC; Lobritto SJ; Martinez M; Vittorio JM; Fox AN; Samstein B; Kato T; Griesemer AD; Emond JC
    Transplantation; 2018 Jun; 102(6):953-960. PubMed ID: 29369249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic benefit of maternal donors in pediatric living donor liver transplantation.
    Kim MH; Akbari O; Genyk Y; Kohli R; Emamaullee J
    Pediatr Transplant; 2019 Nov; 23(7):e13560. PubMed ID: 31402535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Living Donor Liver Transplantation in Children: Surgical and Immunological Results in 250 Recipients at Université Catholique de Louvain.
    Gurevich M; Guy-Viterbo V; Janssen M; Stephenne X; Smets F; Sokal E; Lefebvre C; Balligand JL; Pirotte T; Veyckemans F; Clapuyt P; Menten R; Dumitriu D; Danse E; Annet L; Clety SC; Detaille T; Latinne D; Sempoux C; Laterre PF; de Magnée C; Lerut J; Reding R
    Ann Surg; 2015 Dec; 262(6):1141-9. PubMed ID: 25563870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes in pediatric patients who underwent living donor liver transplantation for biliary atresia.
    Sanada Y; Sakuma Y; Onishi Y; Okada N; Hirata Y; Horiuchi T; Omameuda T; Lefor AK; Sata N
    Surgery; 2022 Jun; 171(6):1671-1676. PubMed ID: 35027207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of transporter associated with antigen processing (TAP) gene polymorphisms in donors with acute cellular rejection in living donor liver transplantation.
    Kamei H; Masuda S; Nakamura T; Oike F; Takada Y; Hamajima N
    J Gastrointestin Liver Dis; 2013 Jun; 22(2):167-71. PubMed ID: 23799215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Donor-Specific Antibodies on Graft Fibrosis After Pediatric Living Donor Liver Transplantation for Biliary Atresia.
    Ueno T; Zenitani M; Yamanaka H; Tanaka N; Uehara S; Tazuke Y; Bessho K; Okuyama H
    Transplant Proc; 2016 May; 48(4):1095-9. PubMed ID: 27320565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody Drug Treatment for Steroid-Resistant Rejection After Pediatric Living Donor Liver Transplantation: A Single-Center Experience.
    Hirata Y; Sanada Y; Urahashi T; Ihara Y; Yamada N; Okada N; Katano T; Otomo S; Ushijima K; Mizuta K
    Transplant Proc; 2018; 50(1):60-65. PubMed ID: 29407332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Living donor liver transplantation for post-Kasai biliary atresia: Analysis of pretransplant predictors of outcomes in infants.
    Kitajima T; Sakamoto S; Sasaki K; Uchida H; Narumoto S; Fukuda A; Teramukai S; Uemoto S; Kasahara M
    Liver Transpl; 2017 Sep; 23(9):1199-1209. PubMed ID: 28590589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretransplantation fetal-maternal microchimerism in pediatric liver transplantation from mother.
    Yi NJ; Park MS; Song EY; Ahn HY; Byun J; Kim H; Hong SK; Yoon K; Kim HS; Ahn SW; Lee HW; Choi Y; Lee KW; Suh KS; Park MH
    World J Gastroenterol; 2017 Dec; 23(45):8017-8026. PubMed ID: 29259377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portal vein thrombosis in biliary atresia patients after living donor liver transplantation.
    Ou HY; Concejero AM; Huang TL; Chen TY; Tsang LL; Chen CL; Yu PC; Yu CY; Cheng YF
    Surgery; 2011 Jan; 149(1):40-7. PubMed ID: 20570300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of acute cellular rejection by peripheral blood eosinophilia in pediatric living donor liver transplantation.
    Sanada Y; Ushijima K; Mizuta K; Urahashi T; Ihara Y; Wakiya T; Okada N; Yamada N; Egami S; Hishikawa S; Otomo S; Sakamoto K; Yasuda Y; Kawarasaki H
    Transplant Proc; 2012 Jun; 44(5):1341-5. PubMed ID: 22664012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
    Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
    Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical complications after living donor liver transplantation in patients with biliary atresia: a relatively high incidence of portal vein complications.
    Takahashi Y; Nishimoto Y; Matsuura T; Hayashida M; Tajiri T; Soejima Y; Taketomi A; Maehara Y; Taguchi T
    Pediatr Surg Int; 2009 Sep; 25(9):745-51. PubMed ID: 19655151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living related liver transplantation: histopathologic analysis of graft dysfunction in 304 patients.
    Minamiguchi S; Sakurai T; Fujita S; Okuno T; Haga H; Mino M; Kanehira K; Matsushiro H; Nakashima Y; Inomata Y; Tanaka K; Yamabe H
    Hum Pathol; 1999 Dec; 30(12):1479-87. PubMed ID: 10667427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for acute liver allograft rejection and their influences on treatment outcomes of rescue therapy in living donor liver transplantation.
    Shindoh J; Akamatsu N; Tanaka T; Kaneko J; Tamura S; Sakamoto Y; Hasegawa K; Sugawara Y; Makuuchi M; Kokudo N
    Clin Transplant; 2016 Aug; 30(8):880-5. PubMed ID: 27146588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living donor liver transplantation in 43 children with biliary atresia: a single-center experience from the mainland of China.
    Zhu JJ; Xia Q; Zhang JJ; Xue F; Chen XS; Li QG; Xu N
    Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):250-5. PubMed ID: 22672817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Living donor liver transplantation in children with cholestatic liver disease: a single-center experience.
    Mizuta K; Urahashi T; Ihara Y; Sanada Y; Wakiya T; Yamada N; Okada N; Egami S; Hishikawa S; Hyodo M; Sakuma Y; Fujiwara T; Kawarasaki H; Yasuda Y
    Transplant Proc; 2012 Mar; 44(2):469-72. PubMed ID: 22410047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.